Infertility News and Research

RSS

Infertility primarily refers to the biological inability of a person to contribute to conception. Infertility may also refer to the state of a woman who is unable to carry a pregnancy to full term.

Women who have child after experiencing fertility problems are more likely to remain with partner

New reseach reveals that women who have a child after experiencing fertility problems are more likely to remain with their partner following infertility evaluations.

30 Jan 2014

Study: About 50% of reproductive-age women never discussed reproductive health with medical provider

A new study by Yale School of Medicine researchers provides insight into how much women of reproductive age in the United States know about reproductive health.

28 Jan 2014

Bariatric surgeon educates patients about bariatric surgeries to achieve healthy weight

While many Americans make New Year's resolutions focused on self-improvement, those who are overweight or obese likely prioritize getting down to a healthy weight.

21 Jan 2014

Risk of serious complications higher for babies conceived by assisted reproductive therapies

A University of Adelaide study has shown that the risk of serious complications such as stillbirth, preterm birth, low birth weight and neonatal death is around twice as high for babies conceived by assisted reproductive therapies compared with naturally conceived babies.

8 Jan 2014

New research shows that as we age, the thermogenic activity of brown fat gets reduced

As most people resolve themselves to lose weight this New Year, here's why it seems to get easier and easier to pack on unwanted pounds: New research published in the January 2014 issue of The FASEB Journal, shows that as we age, the thermogenic activity of brown fat is reduced. Brown fat is a "good" fat located in the backs of our necks that helps burn "bad" white fat around our bellies. Additionally, the researchers also discovered a possible metabolic on/off switch that could reactivate brown fat.

2 Jan 2014

GRU combines with national Cooperative to improve treatment of reproductive health

Georgia Regents University has joined the national Cooperative Multicenter Reproductive Medicine Network designed to enable large clinical trials that improve the diagnosis and treatment of reproductive health issues such as male and female infertility.

2 Jan 2014

European Commission approves update of Erbitux to treat patients with RAS wild-type mCRC

Merck Serono, the biopharmaceutical division of Merck, today announced that the European Commission has approved the Type II variation to amend the Erbitux(cetuximab) product information, updating the indication for Erbitux to the treatment of patients with RAS wild-type metastatic colorectal cancer (mCRC).

23 Dec 2013

Top cancer centers lack policies to protect cancer patients' fertility

Infertility is consistently listed as one of the most distressing long-term side effects of cancer treatment for adolescents and young adults. Yet the leading National Cancer Institute-designated comprehensive cancer centers -- which should be leaders in fertility preservation -- aren't doing an adequate job of helping patients protect their fertility, reports a new Northwestern Medicine- study.

20 Dec 2013

Merck and CNIO sign agreement to collaborate in area of cancer drug development

The Spanish National Cancer Research Centre (CNIO) and the German chemical and pharmaceutical company Merck today signed an agreement in Madrid to collaborate in the area of cancer drug development.

19 Dec 2013

Merck signs license agreement with CNIO for cancer drug development

Merck Serono, the biopharmaceutical division of Merck, today announced that a license agreement has been signed with the Spanish National Cancer Research Centre in Madrid in the area of cancer drug development. The global agreement will build upon CNIO research discoveries to encourage the development and commercialization of new compounds in the field of oncology.

18 Dec 2013

BioLineRx enrolls first patient in BL-7010 Phase 1/2 trial for treatment of celiac disease

BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today enrollment of the first patient in a Phase 1/2 trial of BL-7010, for the treatment of celiac disease. The first patient was enrolled at Tampere Hospital in Finland, a world-leading site for celiac disease research. Results are expected in mid-2014.

18 Dec 2013

Cedars-Sinai physicians awarded grant to study pregnancy problems resulting from fertility treatments

Two Cedars-Sinai physician-researchers have been awarded grants totaling $4 million from the National Institutes of Health to study how the environment - both in the womb and in the hospital where the baby is born - can affect the newborn and the mother.

18 Dec 2013

Endocrine Society issues scientific statement on health consequences of performance-enhancing drugs

A new Scientific Statement issued today by The Endocrine Society represents a comprehensive evaluation of available information on the prevalence and medical consequences of the use of performance-enhancing drugs. The statement highlights the clinical pharmacology, adverse effects and detection of many substances often classified as PEDs, identifies gaps in knowledge and aims to focus the attention of the medical community and policymakers on PED use as an important public health problem.

18 Dec 2013

Queen's University professor wins Gold Award for Innovation for research on male infertility

A Queen's University Professor has received international recognition for her research into male infertility.

16 Dec 2013

New assay allows rapid and sensitive detection of Chlamydia trachomatis

Researchers have developed a new assay for rapid and sensitive detection of Chlamydia trachomatis, the most common sexually transmitted infection (STI) in humans.

12 Dec 2013

Researchers assess direct out-of-pocket costs for couples undergoing fertility treatment

From drug therapy to IVF, out-of pocket costs can range from $900 to $19,000 per treatment cycle, report researchers in The Journal of Urology

9 Dec 2013

New male contraceptive pill could soon be available

A new male contraceptive could be on the horizon after scientists identified a novel way to block the transport of sperm during ejaculation.

4 Dec 2013

EMD Serono's TocopheRx to focus on development of oral FSH agonists for infertility treatment

EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, announced today the creation of TocopheRx, a Boston-based spin-off company resulting from the Entrepreneur Partnership Program launched by Merck Serono, the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, in April 2012.

3 Dec 2013

Women & Infants gets $3M grant to identify infants at greatest risk for developmental impairment

Advances in technology and medical care have dramatically improved survival for infants born prior to 30 weeks gestation and weighing less than three pounds. However, up to 50 percent of these infants may develop physical, cognitive, language and/or behavioral impairments that require extensive health care, educational and psychosocial community resources through adulthood. At this time, there is no reliable method to identify those infants who will go on to develop impairments and those who will not.

19 Nov 2013

Oxford scientists use nanoparticles to study mechanisms underlying 'mystery' cases of infertility

A way of using nanoparticles to investigate the mechanisms underlying 'mystery' cases of infertility has been developed by scientists at Oxford University.

18 Nov 2013

Infertility News and Research

Further Reading

Women who have child after experiencing fertility problems are more likely to remain with partner

Study: About 50% of reproductive-age women never discussed reproductive health with medical provider

Bariatric surgeon educates patients about bariatric surgeries to achieve healthy weight

Risk of serious complications higher for babies conceived by assisted reproductive therapies

New research shows that as we age, the thermogenic activity of brown fat gets reduced

GRU combines with national Cooperative to improve treatment of reproductive health

European Commission approves update of Erbitux to treat patients with RAS wild-type mCRC

Top cancer centers lack policies to protect cancer patients' fertility

Merck and CNIO sign agreement to collaborate in area of cancer drug development

Merck signs license agreement with CNIO for cancer drug development

BioLineRx enrolls first patient in BL-7010 Phase 1/2 trial for treatment of celiac disease

Cedars-Sinai physicians awarded grant to study pregnancy problems resulting from fertility treatments

Endocrine Society issues scientific statement on health consequences of performance-enhancing drugs

Queen's University professor wins Gold Award for Innovation for research on male infertility

New assay allows rapid and sensitive detection of Chlamydia trachomatis

Researchers assess direct out-of-pocket costs for couples undergoing fertility treatment

New male contraceptive pill could soon be available

EMD Serono's TocopheRx to focus on development of oral FSH agonists for infertility treatment

Women & Infants gets $3M grant to identify infants at greatest risk for developmental impairment

Oxford scientists use nanoparticles to study mechanisms underlying 'mystery' cases of infertility

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News